diabetes drug

Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in T2DM

Physician’s Briefing

Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in T2DM

06 Jan 2026

1 min read

Incretin Receptor Agonists Tied to Better Outcomes in Adults With Obesity, T2DM, Obstructive Sleep Apnea

Physician’s Briefing

Incretin Receptor Agonists Tied to Better Outcomes in Adults With Obesity, T2DM, Obstructive Sleep Apnea

05 Jan 2026

1 min read

Clinical Briefing Report

clinicalbriefingreport.com